Navigation Links
Merz Pharmaceuticals Joins Patient Advocates to Raise Awareness of Cervical Dystonia and Blepharospasm
Date:4/14/2011

on (BEBRF) and/or the National Spasmodic Torticollis Association (NSTA). Survey data are unweighted and therefore representative only of the individuals surveyed.

Other Recent XEOMIN News
Reimbursement Support
Merz also recently introduced two comprehensive programs to provide patients with financial assistance for XEOMIN. The XEOMIN Patient Co-payment Program is easy-to-use and offers eligible patients, who are appropriate for treatment with XEOMIN as determined by their physician, assistance for their actual out-of-pocket costs for therapeutic treatment with XEOMIN. Eligible treatment-related costs may include the cost of XEOMIN, associated guidance therapy and related administration fees.

The XEOMIN Patient Assistance Program provides XEOMIN at no cost to eligible patients who are experiencing financial hardship, do not have third-party drug coverage, and who are not eligible for government-funded drug programs.

For more information about reimbursement support and financial assistance programs for XEOMIN, visit www.Xeomin.com, or call 1-888-4-XEOMIN (1-888-493-6646). Dedicated support representatives are available from 8 a.m. until 8 p.m. (EDT), Monday through Friday.

About Cervical Dystonia and Blepharospasm
Dystonias are movement disorders characterized by abnormal, sustained muscle contractions that cause twisting, repetitive movements or abnormal postures in the face, neck, torso and extremities.

Focal dystonias, like cervical dystonia or blepharospasm, affect muscles in a single part of the body. Cervical dystonia causes contractions or spasms of the neck muscles which keep the head from its normal, upright position. It may also cause neck pain. While cervical dystonia may occur at any time, most individuals first experience symptoms near middle age.

Blepharospasm affects the muscles around the eye that you use to blink. It can result i
'/>"/>

SOURCE Merz Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Mpex Pharmaceuticals, Inc. to be Acquired by Axcan
2. Cephalon Lodges Bidders Statement for A$167 Million Offer for ChemGenex Pharmaceuticals
3. Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome
4. Conatus Pharmaceuticals Completes the Second Closing of its Series B Private Placement Financing
5. MAP Pharmaceuticals to Present Data From LEVADEX® Pharmacokinetics and Pharmacodynamics Safety Studies at the 63rd Annual Meeting of the American Academy of Neurology
6. Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
7. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
8. Webcast and Conference Call Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Advances in its Development Pipeline
9. Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX® in EU by Pfizer
10. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
11. Idenix Pharmaceuticals Prices Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
(Date:8/20/2014)... , Aug. 20, 2014   Easy Breathe , the ... that its " Easy Blog " - has received more than ...   "We are thrilled that so many people are ... , CEO of Easy Breathe. "We,re committed to making sleep apnea ... Blog to stay informed about sleep apnea news , ...
(Date:8/20/2014)... YORK, Aug 20, 2014 Reportlinker.com announces ... in its catalogue: Global Patient Scales ... This report analyzes the worldwide markets for ... Product Segments: Floor Scales, Infant & Baby Scales, ... provides separate comprehensive analytics for the US, Canada, ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19
... , , , OSAKA, Japan, ... announced today positive results from PEARL 2 - a ... In this trial, both lurasidone 40 and 120 mg/day were significantly more ... an overall discontinuation rate that was similar to placebo. , , ...
... , , , ... CXM ) today announced that all patients enrolled in the Company,s ... and that it plans to provide detailed safety and efficacy data ... http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ) , , The Phase 2b MATRIX ...
Cached Medicine Technology:Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study 2Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study 3Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study 4Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study 5Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 2Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 3Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 5Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 6Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 7Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 8
(Date:8/20/2014)... 20, 2014 The National Association ... $1.24 million Science Education Partnership Award (SEPA) grant ... NAHN’s collaborative project with the Hispanic Communications Network ... , This collaborative NIH R25 program has been ... linguistic diversity among health professionals by recruiting and ...
(Date:8/20/2014)... City, New Jersey (PRWEB) August 20, 2014 ... in meeting the needs of an estimated tens of ... introduction of the new Bill A3525—a bill that would ... patients to grow their own cannabis—earlier this summer by ... horticultural training for medicinal quality marijuana is growing. , ...
(Date:8/20/2014)... 20, 2014 Verndale is pleased to ... list; an exclusive list ranking the fastest-growing private companies ... according to their yearly percentage revenue growth over a ... on the Inc. 5000 list where it ranked number ... offers its clients a wide range of digital marketing ...
(Date:8/20/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief operating officer ... Ore. The top executive search firm in ... more than 900 healthcare executives into organizations. , ... healthcare organization serving a population of more than 35,000 ...
(Date:8/20/2014)... Biosimilars, which are similar versions ... an abbreviated process, could reap billions in health ... Services, Inc.’s (AIS) Specialty Pharmacy News offers coverage ... Food and Drug Administration’s (FDA) recent acceptance of ... , Drugmaker Sandoz said July 24 that the ...
Breaking Medicine News(10 mins):Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 2Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 3Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3
... and treated in many cases, say US doctors. In peripheral ... become blocked with the same kind of fatty deposits - ... of treating it is very simple - keep walking. While ... the ability to walk with ease. Positive effects are seen ...
... Nearly half of people with Parkinson's disease are using one ... as vitamins, message or acupuncture. Researchers at Johns Hopkins University ... than 200 people with Parkinson's disease. Forty per cent use ... cent use five or more different ones. There's no link ...
... Bubonic plague, the bacterium blamed for the Black Death ... biological weapon, has had its entire genome sequenced. The ... and picking up new genes from other microbes. ,That ... emerge. More ominously, it suggests that enhanced strains might ...
... with a skin condition called contact dermatitis may benefit from ... tomatoes, according to the results of a small study.// Individuals ... they come in contact with substances they are allergic to. ... the skin, and many people may not realize foods can ...
... New research confirms that the main ingredient in the -- ... loss when used long term. The younger you are when ... bone-related problems later in life. // ... our bone mass is constantly breaking down and re-building, usually ...
... Suppression of testosterone levels in men with testicular ... disease, warn US researchers.,A research team from North ... levels go down, a high rise in levels ... disease – occurs. They suggest that this phenomenon ...
Cached Medicine News:Health News:Sequencing of the Plague 2
... AMO Prestige System marked an amazing ... of safety with high-performance fluidics.A.S.E.T. keeps ... conditions in the in the anterior ... the reaction and interaction of the ...
Highly versatile, efficient, compact and accurate digital readout display....
... system has all the features of phaco ... engineering means minimal maintenance. Small, light and ... to site. Lowest cost reusable tubing kit ... longer is there a price objection to ...
The CV-12000 provides the surgeon with all the options to perform today's newest techniques....
Medicine Products: